Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noa Bregman

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Alzheimer'S Research & Therapy|June 30, 2026
Lecanemab in practice: AI-derived MRI predictors of benefit and Amyloid Related Imaging Abnormalities (ARIA)Noa Bregman, Nuno Pedrosa de Barros, Talya Nathan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 31, 2024
White matter abnormalities in healthy E200K carriers may serve as an early biomarker for genetic Creutzfeldt-Jakob disease (gCJD)Nurit Omer, Amgad Droby, Rawan Silbak, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 24, 2026
Alpha-synuclein co-pathology in a real-world early Alzheimer's disease cohortTamara Shiner, Talya Nathan, Mori Hai Levy, et al.
European Journal of Neurology|October 21, 2024
Brain health and national neurological societies: Results of the European Academy of Neurology survey on brain health awareness and areas of implementation for European countriesMatilde Leonardi, Isabella Colonna, David Garcia-Azorin, et al.
European Journal of Neurology|June 23, 2026
A Practice Framework for Genetic Testing in Asymptomatic Relatives of Patients With Creutzfeldt-Jakob Disease: Experience and Insights From IsraelDror Shir, Noa Bregman, Aya Bar David, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Alzheimer'S Research & Therapy|June 30, 2026
Lecanemab in practice: AI-derived MRI predictors of benefit and Amyloid Related Imaging Abnormalities (ARIA)Noa Bregman, Nuno Pedrosa de Barros, Talya Nathan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 31, 2024
White matter abnormalities in healthy E200K carriers may serve as an early biomarker for genetic Creutzfeldt-Jakob disease (gCJD)Nurit Omer, Amgad Droby, Rawan Silbak, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 24, 2026
Alpha-synuclein co-pathology in a real-world early Alzheimer's disease cohortTamara Shiner, Talya Nathan, Mori Hai Levy, et al.
European Journal of Neurology|October 21, 2024
Brain health and national neurological societies: Results of the European Academy of Neurology survey on brain health awareness and areas of implementation for European countriesMatilde Leonardi, Isabella Colonna, David Garcia-Azorin, et al.
European Journal of Neurology|June 23, 2026
A Practice Framework for Genetic Testing in Asymptomatic Relatives of Patients With Creutzfeldt-Jakob Disease: Experience and Insights From IsraelDror Shir, Noa Bregman, Aya Bar David, et al.
Pageof 5